atropine
RxNorm concept 1223, ingredient (in).
- RxCUI
- 1223
- Term type
- Ingredient (IN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1223 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Lomotil (BN, has tradename)
- Isopto Atropine (BN, has tradename)
- Donnatal (BN, has tradename)
- Motofen (BN, has tradename)
- Atropen (BN, has tradename)
- Duodote (BN, has tradename)
- Phenohytro (BN, has tradename)
- atropine Injectable Solution (SCDF, ingredient of)
- atropine Ophthalmic Solution (SCDF, ingredient of)
- atropine / difenoxin Oral Tablet (SCDF, ingredient of)
- atropine / diphenoxylate Oral Solution (SCDF, ingredient of)
- atropine / diphenoxylate Oral Tablet (SCDF, ingredient of)
- atropine Ophthalmic Ointment (SCDF, ingredient of)
- atropine / hyoscyamine / phenobarbital / scopolamine Oral Tablet (SCDF, ingredient of)
- atropine / hyoscyamine / phenobarbital / scopolamine Extended Release Oral Tablet (SCDF, ingredient of)
- atropine / chlorpheniramine / hyoscyamine / pseudoephedrine / scopolamine Extended Release Oral Tablet (SCDF, ingredient of)
- atropine Prefilled Syringe (SCDF, ingredient of)
- atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution (SCDF, ingredient of)
- atropine sulfate 0.04 MG (SCDC, ingredient of)
- atropine sulfate 0.00388 MG/ML (SCDC, ingredient of)
- atropine sulfate 0.0194 MG (SCDC, ingredient of)
- atropine sulfate 0.0582 MG (SCDC, ingredient of)
- atropine sulfate 0.025 MG (SCDC, ingredient of)
- atropine / chlorpheniramine / hyoscyamine / pseudoephedrine / scopolamine Oral Product (SCDG, ingredient of)
- atropine / chlorpheniramine / hyoscyamine / pseudoephedrine / scopolamine Pill (SCDG, ingredient of)
- atropine / diphenoxylate Oral Liquid Product (SCDG, ingredient of)
- atropine / diphenoxylate Oral Product (SCDG, ingredient of)
- atropine / diphenoxylate Pill (SCDG, ingredient of)
- atropine / hyoscyamine / phenobarbital / scopolamine Oral Liquid Product (SCDG, ingredient of)
- atropine / hyoscyamine / phenobarbital / scopolamine Oral Product (SCDG, ingredient of)
- atropine / hyoscyamine / phenobarbital / scopolamine Pill (SCDG, ingredient of)
- atropine / difenoxin Oral Product (SCDG, ingredient of)
- atropine / difenoxin Pill (SCDG, ingredient of)
- atropine / pralidoxime Injectable Product (SCDG, ingredient of)
- atropine Injectable Product (SCDG, ingredient of)
- atropine Ophthalmic Product (SCDG, ingredient of)
- atropine sulfate 0.714 MG/ML (SCDC, ingredient of)
- atropine sulfate 1.43 MG/ML (SCDC, ingredient of)
- atropine sulfate 2.86 MG/ML (SCDC, ingredient of)
- atropine sulfate 0.1 MG/ML (SCDC, ingredient of)
- atropine sulfate 0.05 MG/ML (SCDC, ingredient of)
- atropine sulfate 0.4 MG/ML (SCDC, ingredient of)
- atropine sulfate 0.005 MG/ML (SCDC, ingredient of)
- atropine sulfate 0.01 MG/MG (SCDC, ingredient of)
- atropine sulfate 10 MG/ML (SCDC, ingredient of)
- atropine sulfate 1 MG/ML (SCDC, ingredient of)
- atropine / pralidoxime Auto-Injector (SCDF, ingredient of)
- atropine 0.778 MG/ML (SCDC, ingredient of)
- atropine Injection (SCDF, ingredient of)
- atropine Auto-Injector (SCDF, ingredient of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1223 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1223 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1223. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.